Stenting, but not endarterectomy, significantly reduced stroke risk compared with intensive medical therapy alone.
CREST-2 showed that, among patients with high-grade carotid stenosis without recent neurological symptoms, the addition of stenting led to significantly better outcomes than intensive medical ...
TipRanks on MSN
InspireMD announces publication of CREST-2 data in NEJM
InspireMD (NSPR) announced the recent presentation and publication of CREST-2 data which demonstrated positive clinical outcomes for carotid ...
The results of the ongoing CREST-2 study in patients with asymptomatic, high-grade carotid artery stenosis are still several years away. But new data out of a companion registry suggest that whatever ...
TEL AVIV, Israel and MIAMI, Aug. 05, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today congratulated ...
CREST-2 (clinicaltrials.gov number: NCT02089217) is a pair of parallel, actively recruiting procedural trials to prevent stroke comparing: 1) carotid endarterectomy (CEA) and intensive medical ...
A low rate of periprocedural stroke/death with carotid stenting for both asymptomatic and symptomatic patients has been reported in a new registry study. The CREST-2 Registry study found that 30-day ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback